Acta Pharmacol Sin 47 , 162172 (2026)
Tirzepatide may be appropriate for some patients seeking greater average weight-loss outcomes, while Ozempic may be a suitable option for others based on their medical history, treatment goals, insurance coverage, and clinician's recommendation
Announcing Regenerative Neurological Therapy A New Non-Invasive Intranasal Approach to Delivering Stem Cells, Exosomes, and Peptides to the Brain Looking Beyond Surgery Low back pain is the leading cause of disability worldwide, and nearly 80% of adults will experience significant low back pain at some point
For older, existing leg scars, home remedies, such as oil massages, may improve appearance, but are unlikely to remove them fully
The active ingredient is identical between Mounjaro and Zepbound, but the FDA indication and insurance coverage pathway differ, which matters if OSA is part of your medical picture
This was verified using secondary sources and by industry experts